Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp69 | Cardiovascular | ECE2018

Can monogenic severe hypertriglyceridemia be differentiated from polygenic forms through clinical features: data from APPROACH and COMPASS studies in FCS and non-FCS hypertriglyceridemic patients?

O'Dea Louis , MacDougall James , Digenio Andres , Hubbard Brant , Arca Marcello , Moriarty Patrick , Kastelein John , Bruckert Eric , Witztum Joseph

Introduction: Differentiation between familial chylomicronemia syndrome (FCS), a rare hypertriglyceridemia, and severe hypertriglyceridemia (sHTG; non-FCS) is challenging due to overlap in triglyceride (TG) levels and symptomology but important in disease management. Clinical characteristics that allow for reliable differentiation may exist in the presenting clinical features and primary diagnostic testing. The objective of this analysis was to assess whether readily obtainabl...

ea0032p687 | Neuroendocrinology | ECE2013

Digenic and oligogenic cases in a large cohort of idiopathic central hypogonadism (ICH) patients

Libri Domenico , Bonomi Marco , Guizzardi Fabiana , Duminuco Paolo , Pincelli Ida , Russo Giovanni , Garolla Andrea , Krausz Csilla , Maghnie Mohamed , Padova Giuseppa , Persani Luca

ICH is a rare and heterogeneous condition due to defects in the onthogenesis, migration and action of GnRH secreting neurons. Recent publications indicate that ICH, though characterized by a strong genetic component, is a disease of multifactorial origin. Indeed, digenic and oligogenic defects have been described as a possible pathogenic explanation for this disease. Among the cohort of 315 ICH patients we identified 3 KS and 7 nICH patients (7 males, 3 females) with a biallel...

ea0038p358 | Reproduction | SFEBES2015

Isoform-specific knockdown of PKC isoforms reveals PKCβ2 is required for epidermal growth factor stimulated expression of the prostaglandin synthase COX2 in human myometrium

Hudson Claire , Bernal Andres Lopez

Intrauterine prostaglandin (PG) synthesis and release are key components of human labour at term and pre-term, resulting in synchronised membrane rupture, cervical dilation and myometrial contractility. A key mediator of uterine PG production is the highly inducible enzyme cyclooxygenase 2 (COX2 or PTGS2). Epidermal growth factor (EGF) is released by the foetus during pregnancy and amniotic fluid levels rise rapidly during late gestation, moreover EGF stimulates expression of ...

ea0035p1042 | Thyroid (non-cancer) | ECE2014

Antithyroid drug-induced agranulocytosis: experience of the French centers of Pharmacovigilance with a retrospective study of more than 200 cases

Andres Emmanuel , Weitten Thierry , Alt-Tebacher Martine

Objective: Agranulocytosis to the antithyroid drugs is a rare adverse drug effect exposure to potentially lethal infections. It is a public health problem with hyperthyroidism in nearly 1% of the French population. However, many uncertainties remain in the knowledge, understanding, prevention and management of this drug effect. In this work, we report the French experience through pharmacovigilance data.Materials and methods: This is a retrospective stud...

ea0016p522 | Obesity | ECE2008

Glucose-dependent insulinotropic polypeptide downregulates expression and enzyme activity of 11β-Hydroxysteroid Dehydrogenase type 1

Andres Janin , Gogebakan Ozlem , Mai Knut , Pfeiffer Andreas , Spranger Joachim

Introduction: 11β-hydroxysteroid dehydrogenase type 1 (11 β-HSD1) converts cortisone into its active metabolite, cortisol. Mechanisms regulating the promoter-activity of 11β-HSD1 are of considerable importance to understand the basics of intracellular cortisol, lipid and glucose metabolism. The incretine glucose-dependent insulinotropic polypeptide (GIP) has been suggested to affect insulin sensitivity. However, the mechanisms of this effect are unclear yet....

ea0016p179 | Diabetes and cardiovascular diseases | ECE2008

Degree of control of cardiovascular risk factors (CRFs) in patients with type 2 diabetes mellitus (T2DM) stratified by diabetes therapy

Javier del Canizo-Gomez Francisco , Moreira-Andres Maria Natividad

Control of CRFs in T2DM patients results in a clinically important reduction in the risk of death and complications related to diabetes.Objective: To assess the degree of control of modifiable CRFs in treated T2DM patients, stratified by diabetes therapy.Materials and methods: Cross-sectional study in 574 T2DM patients who attended our clinic for a routine follow-up. Fasting plasma glucose (FPG), HbA1C, HDL-Cholesterol (HDL-Ch), LD...

ea0022p510 | Growth factors | ECE2010

Growth failure in a girl harbouring digenic heterozygote mutations in the Ferroportin1-gene and the HFE-gene

Janner Marco , Fluck Christa , Galllati Sabina , Mullis Primus

Background: GH deficiency due to iron overload is well known in thalassaemic children, yet this association has not been described in children with haemochromatosis.Case report and methods: We report on a girl who was first seen at the age of 9.6 years (height 117.5 cm, −3.3 SDS, weight 21 kg, −2.5 SDS). She had a normal physical examination and was prepubertal. Target height-SDS was −0.9. Her bone age was delayed by 10 months. IGF1 was...

ea0020p464 | Obesity and Metabolism | ECE2009

Glucose-dependent insulinotropic polypeptide increases glucose-uptake in muscle- and adipocyte cells in vitro

Andres Janin , Biedasek Katrin , Goegebakan Ozlem , Mai Knut , Pfeiffer Andreas , Spranger Joachim

Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone secreted by K-cells of proximal small intestine that is secreted postprandial in response to glucose and fat ingestion. Its effect is mediated through a GIP receptor (GIPR) which is widely expressed in different tissues, e.g. pancreatic islets, adipose tissue, skeletal muscle, adrenal cortex, heart, pituitary and in some regions of the brain. However, only the effect of GIP in pancreatic beta-cells is we...

ea0063p310 | Reproductive Endocrinology 1 | ECE2019

Diagnosis and management of severe hyperandrogenism in the context of tumoral suspicion: case-series report from a tertiary hospital

Ortiz-Flores Andres , Luque-Ramirez Manuel , Fernandez-Duran Elena , Vega-Pineiro Belen , Escobar-Morreale Hector

Background: The finding of severe hyperandrogenemia, rapidly progressive clinical hyperandrogenism, defeminization and/or virilization in women of any age should raise the suspicion of an ovarian or adrenal malignancy. Similarly, moderate to severe hyperandrogenemia after menopause, and its clinic consequences, force clinicians to rule out a tumoral source.Matherial and methods: Observational cross-sectional study conducted in patients derived to our cli...

ea0049ep986 | Pituitary - Clinical | ECE2017

Long-term impact of primary medical and surgical therapy on bone density in men versus women with prolactinomas

Andereggen Lukas , Frey Janine , Andres Robert , El-Koussy Marwan , Beck Jurgen , Mariani Luigi , Christ Emanuel

Purpose: The prevalence of pathological bone densities in men and women with prolactinomas treated either primary surgically or medically are infrequently reported across large cohorts. In the present study, we aimed at comparing the impact of either therapeutic approach on the bone density in men vs women with prolactinomas.Methods: Retrospective case-note study including all consecutive patients with prolactinomas in whom osteodensitometry data was ava...